tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Balanced Risk–Reward for Insulet: Strong Growth but Rising Competition Justifies Hold Rating and $294 Target
PremiumRatingsBalanced Risk–Reward for Insulet: Strong Growth but Rising Competition Justifies Hold Rating and $294 Target
9d ago
Insulet Completes Key Omnipod 5 SmartAdjust 2.0 Study, Setting Up Next Growth Phase
Premium
Company Announcements
Insulet Completes Key Omnipod 5 SmartAdjust 2.0 Study, Setting Up Next Growth Phase
14d ago
Netflix initiated, Palantir upgraded: Wall Street’s top analyst calls
Premium
The Fly
Netflix initiated, Palantir upgraded: Wall Street’s top analyst calls
24d ago
Insulet’s New Omnipod M Study Targets the Untapped Type 2 Diabetes Pump Market
PremiumCompany AnnouncementsInsulet’s New Omnipod M Study Targets the Untapped Type 2 Diabetes Pump Market
2M ago
Insulet’s Omnipod SmartAdjust 2.0 Trial Wraps Up: What Investors Should Watch Next
Premium
Company Announcements
Insulet’s Omnipod SmartAdjust 2.0 Trial Wraps Up: What Investors Should Watch Next
2M ago
Insulet price target lowered to $390 from $412 at Truist
Premium
The Fly
Insulet price target lowered to $390 from $412 at Truist
2M ago
3 “Strong Buy” Growth Stocks to Buy Now, According to Analysts – 12/8/2025
PremiumMarket News3 “Strong Buy” Growth Stocks to Buy Now, According to Analysts – 12/8/2025
2M ago
Insulet gets FDA clearance for updates to Omnipod 5 Automated Insulin Delivery
Premium
The Fly
Insulet gets FDA clearance for updates to Omnipod 5 Automated Insulin Delivery
2M ago
Insulet price target raised to $432 from $428 at Canaccord
Premium
The Fly
Insulet price target raised to $432 from $428 at Canaccord
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100